1. Home
  2. CMRX
  3. CMRX News

Latest Chimerix Inc. (CMRX) News on April 4, 2025

Is Chimerix Inc. (CMRX) the Best Performing NASDAQ Stock So Far in 2025?
CMRX

Insider Monkey

3 days ago

Is Chimerix Inc. (CMRX) the Best Performing NASDAQ Stock So Far in 2025?

Exploring US High Growth Tech Stocks In March 2025
CMRX

Simply Wall St.

4 days ago

Exploring US High Growth Tech Stocks In March 2025

Chimerix Inc. (NASDAQ:CMRX) Amazing Performance So Far In 2025
CMRX

Insider Monkey

9 days ago

Chimerix Inc. (NASDAQ:CMRX) Amazing Performance So Far In 2025

CMRX

Associated Press Finance

14 days ago

Chimerix: Q4 Earnings Snapshot

Chimerix Reports Fourth Quarter and Year End 2024 Financial Results
CMRX

GlobeNewswire

14 days ago

Chimerix Reports Fourth Quarter and Year End 2024 Financial Results

LTRN: M&A Illuminates GBM Value
CMRX

Zacks Small Cap Research

25 days ago

LTRN: M&A Illuminates GBM Value

Why Chimerix, Inc. (CMRX) Soared Last Week
CMRX

Insider Monkey

25 days ago

Why Chimerix, Inc. (CMRX) Soared Last Week

Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CMRX

GlobeNewswire

a month ago

Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

The Zacks Analyst Blog Jazz Pharmaceuticals, Chimerix, Moderna, GSK and Regeneron Pharmaceuticals
CMRX

Zacks

a month ago

The Zacks Analyst Blog Jazz Pharmaceuticals, Chimerix, Moderna, GSK and Regeneron Pharmaceuticals

Biotech Stocks Roundup: CMRX Up on JAZZ Bid, MRNA Up on Updates & More
CMRX

Zacks

a month ago

Biotech Stocks Roundup: CMRX Up on JAZZ Bid, MRNA Up on Updates & More

CMRX

MT Newswires

a month ago

Update: Truist Raises PT on Jazz Pharmaceuticals to $230 From $220 on Heels of Announced Purchase of Chimerix, Keeps Buy Rating

Chimerix downgraded to Neutral from Buy at H.C. Wainwright
CMRX

TipRanks

a month ago

Chimerix downgraded to Neutral from Buy at H.C. Wainwright

Jazz Offers to Buy Chimerix for $935M to Boost Oncology Portfolio
CMRX

Zacks

a month ago

Jazz Offers to Buy Chimerix for $935M to Boost Oncology Portfolio

Jazz Pharmaceuticals bids for Chimerix in $935m deal
CMRX

Pharmaceutical Technology

a month ago

Jazz Pharmaceuticals bids for Chimerix in $935m deal

CMRX

MT Newswires

a month ago

Jefferies Downgrades Chimerix to Hold From Buy, Price Target is $8.50

CMRX

MT Newswires

a month ago

Chimerix a Prime Acquisition Candidate for Jazz Pharmaceuticals Due to Dordaviprone, Wedbush Says

CMRX

MT Newswires

a month ago

Wedbush Downgrades Chimerix to Neutral From Outperform, Adjusts Price Target to $8.55 From $7

CMRX

MT Newswires

a month ago

Jazz Pharmaceuticals to Acquire Chimerix in $935 Million Deal

Jazz Pharmaceuticals to Acquire Chimerix, Further Diversifying Oncology Portfolio
CMRX

PR Newswire

a month ago

Jazz Pharmaceuticals to Acquire Chimerix, Further Diversifying Oncology Portfolio

Jazz expands in oncology with $935M deal for Chimerix
CMRX

BioPharma Dive

a month ago

Jazz expands in oncology with $935M deal for Chimerix

Exploring Three High Growth Tech Stocks in the United States
CMRX

Simply Wall St.

a month ago

Exploring Three High Growth Tech Stocks in the United States

Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CMRX

GlobeNewswire

a month ago

Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

CMRX

MT Newswires

a month ago

Sector Update: Health Care Stocks Mixed Late Afternoon

CMRX

MT Newswires

a month ago

Sector Update: Health Care

CMRX

MT Newswires

a month ago

Chimerix Says FDA Grants Priority Review for New Drug Application of Cancer Treatment Dordaviprone; Shares Rise

CMRX

MT Newswires

a month ago

Wedbush Adjusts Price Target on Chimerix to $7 From $6, Keeps Outperform Rating

Chimerix Announces FDA Acceptance and Priority Review of New Drug Application for Dordaviprone as Treatment for Recurrent H3 K27M-Mutant Diffuse Glioma
CMRX

GlobeNewswire

a month ago

Chimerix Announces FDA Acceptance and Priority Review of New Drug Application for Dordaviprone as Treatment for Recurrent H3 K27M-Mutant Diffuse Glioma

Metalpha Technology Holding And 2 Other US Penny Stocks To Monitor
CMRX

Simply Wall St.

2 months ago

Metalpha Technology Holding And 2 Other US Penny Stocks To Monitor

CMRX Stock Skyrockets in 3 Months: Here's What You Should Know
CMRX

Zacks

2 months ago

CMRX Stock Skyrockets in 3 Months: Here's What You Should Know

Chimerix to Present at JonesTrading Virtual Precision Medicine Symposium
CMRX

GlobeNewswire

2 months ago

Chimerix to Present at JonesTrading Virtual Precision Medicine Symposium

Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CMRX

GlobeNewswire

2 months ago

Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

US Penny Stocks To Watch In January 2025
CMRX

Simply Wall St.

3 months ago

US Penny Stocks To Watch In January 2025

Here’s Why Chimerix, Inc. (CMRX) Is Skyrocketing
CMRX

Insider Monkey

3 months ago

Here’s Why Chimerix, Inc. (CMRX) Is Skyrocketing

Chimerix to Speak Today at The White House Cancer Moonshot Forum
CMRX

GlobeNewswire

3 months ago

Chimerix to Speak Today at The White House Cancer Moonshot Forum

CMRX

MT Newswires

3 months ago

Chimerix Seeks Accelerated FDA Approval for Experimental Tumor Drug

Chimerix Submits Dordaviprone New Drug Application for Accelerated Approval to U.S. FDA for Patients with Recurrent H3 K27M-Mutant Diffuse Glioma
CMRX

GlobeNewswire

3 months ago

Chimerix Submits Dordaviprone New Drug Application for Accelerated Approval to U.S. FDA for Patients with Recurrent H3 K27M-Mutant Diffuse Glioma

3 Promising Penny Stocks With Market Caps Under $2B In US
CMRX

Simply Wall St.

4 months ago

3 Promising Penny Stocks With Market Caps Under $2B In US

CMRX

MT Newswires

4 months ago

Sector Update: Health Care Stocks Decline Late Afternoon

Chimerix Soars 220% on FDA Filing Plans for Lifesaving Brain Cancer Therapy
CMRX

GuruFocus.com

4 months ago

Chimerix Soars 220% on FDA Filing Plans for Lifesaving Brain Cancer Therapy

CMRX

MT Newswires

4 months ago

Chimerix Shares Soar Following Plans to Seek Accelerated Approval for Dordaviprone in Rare Brain Tumor

CMRX

MT Newswires

4 months ago

Top Midday Gainers

Why Is Cancer-Focused Chimerix Stock Trading Higher On Tuesday?
CMRX

Benzinga

4 months ago

Why Is Cancer-Focused Chimerix Stock Trading Higher On Tuesday?

Chimerix to Submit Dordaviprone for Accelerated Approval to U.S. FDA for Patients with Recurrent H3 K27M-Mutant Diffuse Glioma Before Year-End
CMRX

GlobeNewswire

4 months ago

Chimerix to Submit Dordaviprone for Accelerated Approval to U.S. FDA for Patients with Recurrent H3 K27M-Mutant Diffuse Glioma Before Year-End

Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CMRX

GlobeNewswire

4 months ago

Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Chimerix Announces Updated Phase 2 Response Assessment of Dordaviprone in Recurrent H3 K27M Glioma at the 2024 SNO Meeting
CMRX

GlobeNewswire

5 months ago

Chimerix Announces Updated Phase 2 Response Assessment of Dordaviprone in Recurrent H3 K27M Glioma at the 2024 SNO Meeting

Chimerix Third Quarter 2024 Earnings: Misses Expectations
CMRX

Simply Wall St.

5 months ago

Chimerix Third Quarter 2024 Earnings: Misses Expectations

CMRX

Thomson Reuters StreetEvents

5 months ago

Q3 2024 Chimerix Inc Earnings Call

Chimerix Inc (CMRX) Q3 2024 Earnings Call Highlights: Strategic Advancements Amid Financial ...
CMRX

GuruFocus.com

5 months ago

Chimerix Inc (CMRX) Q3 2024 Earnings Call Highlights: Strategic Advancements Amid Financial ...

Chimerix (CMRX) Reports Q3 Loss, Lags Revenue Estimates
CMRX

Zacks

5 months ago

Chimerix (CMRX) Reports Q3 Loss, Lags Revenue Estimates

CMRX

Associated Press Finance

5 months ago

Chimerix: Q3 Earnings Snapshot

Chimerix Reports Third Quarter 2024 Financial Results and Provides Operational Update
CMRX

GlobeNewswire

5 months ago

Chimerix Reports Third Quarter 2024 Financial Results and Provides Operational Update

Chimerix Inc (CMRX) Q3 2024: Everything You Need to Know Ahead of Earnings
CMRX

GuruFocus.com

5 months ago

Chimerix Inc (CMRX) Q3 2024: Everything You Need to Know Ahead of Earnings

LiveOne Leads The Pack Of 3 US Penny Stocks
CMRX

Simply Wall St.

5 months ago

LiveOne Leads The Pack Of 3 US Penny Stocks

Chimerix to Report Third Quarter 2024 Financial Results and Provide an Operational Update on November 7, 2024
CMRX

GlobeNewswire

5 months ago

Chimerix to Report Third Quarter 2024 Financial Results and Provide an Operational Update on November 7, 2024

Chimerix Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
CMRX

GlobeNewswire

6 months ago

Chimerix Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

0246810AI: Slightly Positive
Here's Why We're Watching Chimerix's (NASDAQ:CMRX) Cash Burn Situation
CMRX

Simply Wall St.

6 months ago

Here's Why We're Watching Chimerix's (NASDAQ:CMRX) Cash Burn Situation

0246810AI: Neutral
Chimerix to Present at H.C. Wainwright 26th Annual Global Investment Conference
CMRX

GlobeNewswire

7 months ago

Chimerix to Present at H.C. Wainwright 26th Annual Global Investment Conference

0246810AI: Highly Positive
Chimerix Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
CMRX

GlobeNewswire

7 months ago

Chimerix Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

0246810AI: Neutral
CMRX

Thomson Reuters StreetEvents

8 months ago

Q2 2024 Chimerix Inc Earnings Call

0246810AI: Neutral
Chimerix (CMRX) Reports Q2 Loss, Misses Revenue Estimates
CMRX

Zacks

8 months ago

Chimerix (CMRX) Reports Q2 Loss, Misses Revenue Estimates

0246810AI: Slightly Positive
CMRX

Associated Press Finance

8 months ago

Chimerix: Q2 Earnings Snapshot

0246810AI: Neutral
Chimerix Reports Second Quarter 2024 Financial Results and Provides Operational Update
CMRX

GlobeNewswire

8 months ago

Chimerix Reports Second Quarter 2024 Financial Results and Provides Operational Update

0246810AI: Positive
Chimerix to Report Second Quarter 2024 Financial Results and Provide an Operational Update on August 13, 2024
CMRX

GlobeNewswire

8 months ago

Chimerix to Report Second Quarter 2024 Financial Results and Provide an Operational Update on August 13, 2024

0246810AI: Highly Positive
Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CMRX

GlobeNewswire

9 months ago

Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

0246810AI: Neutral
Chimerix to Participate in Fireside Chat at Jefferies Global Healthcare Conference
CMRX

GlobeNewswire

10 months ago

Chimerix to Participate in Fireside Chat at Jefferies Global Healthcare Conference

0246810AI: Highly Positive
Chimerix, Inc. (NASDAQ:CMRX) Q1 2024 Earnings Call Transcript
CMRX

Insider Monkey

a year ago

Chimerix, Inc. (NASDAQ:CMRX) Q1 2024 Earnings Call Transcript

0246810AI: Neutral
CMRX

GuruFocus.com

a year ago

Chimerix Inc (CMRX) Q1 2024 Earnings Call Transcript Highlights: Strategic Developments and ...

0246810AI: Neutral
CMRX

Thomson Reuters StreetEvents

a year ago

Q1 2024 Chimerix Inc Earnings Call

0246810AI: Positive
CMRX

Associated Press Finance

a year ago

Chimerix: Q1 Earnings Snapshot

0246810AI: Neutral
Chimerix Reports First Quarter 2024 Financial Results and Provides Operational Update
CMRX

GlobeNewswire

a year ago

Chimerix Reports First Quarter 2024 Financial Results and Provides Operational Update

0246810AI: Highly Positive
Chimerix to Report First Quarter 2024 Financial Results and Provide an Operational Update on May 1, 2024
CMRX

GlobeNewswire

a year ago

Chimerix to Report First Quarter 2024 Financial Results and Provide an Operational Update on May 1, 2024

0246810AI: Highly Positive
Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CMRX

GlobeNewswire

a year ago

Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

0246810AI: Neutral
We Think Chimerix (NASDAQ:CMRX) Needs To Drive Business Growth Carefully
CMRX

Simply Wall St.

a year ago

We Think Chimerix (NASDAQ:CMRX) Needs To Drive Business Growth Carefully

0246810AI: Neutral
Chimerix Appoints Marc D. Kozin to Board of Directors
CMRX

GlobeNewswire

a year ago

Chimerix Appoints Marc D. Kozin to Board of Directors

0246810AI: Highly Positive
Chimerix Full Year 2023 Earnings: EPS Beats Expectations, Revenues Lag
CMRX

Simply Wall St.

a year ago

Chimerix Full Year 2023 Earnings: EPS Beats Expectations, Revenues Lag

Chimerix, Inc. (NASDAQ:CMRX) Q4 2023 Earnings Call Transcript
CMRX

Insider Monkey

a year ago

Chimerix, Inc. (NASDAQ:CMRX) Q4 2023 Earnings Call Transcript

CMRX

Thomson Reuters StreetEvents

a year ago

Q4 2023 Chimerix Inc Earnings Call

Chimerix Inc Reports Fourth Quarter and Full-Year 2023 Financial Results
CMRX

GuruFocus.com

a year ago

Chimerix Inc Reports Fourth Quarter and Full-Year 2023 Financial Results

CMRX

Associated Press Finance

a year ago

Chimerix: Q4 Earnings Snapshot

Chimerix Reports Fourth Quarter and Year End 2023 Financial Results and Provides Operational Update
CMRX

GlobeNewswire

a year ago

Chimerix Reports Fourth Quarter and Year End 2023 Financial Results and Provides Operational Update

Chimerix to Present at TD Cowen 44th Annual Health Care Conference
CMRX

GlobeNewswire

a year ago

Chimerix to Present at TD Cowen 44th Annual Health Care Conference

Chimerix to Report Fourth Quarter and Year End 2023 Financial Results and Provide an Operational Update on February 29, 2024
CMRX

GlobeNewswire

a year ago

Chimerix to Report Fourth Quarter and Year End 2023 Financial Results and Provide an Operational Update on February 29, 2024

Chimerix, Inc. (NASDAQ:CMRX) surges 24%; individual investors who own 43% shares profited along with institutions
CMRX

Simply Wall St.

a year ago

Chimerix, Inc. (NASDAQ:CMRX) surges 24%; individual investors who own 43% shares profited along with institutions

Clearfield (CLFD) Declined in 2023
CMRX

Insider Monkey

a year ago

Clearfield (CLFD) Declined in 2023

Why First Savings Financial (FSFG) is a Great Dividend Stock Right Now
CMRX

Zacks

a year ago

Why First Savings Financial (FSFG) is a Great Dividend Stock Right Now

Elevation Oncology Announces Appointment of Darcy Mootz, Ph.D., to its Board of Directors
CMRX

PR Newswire

a year ago

Elevation Oncology Announces Appointment of Darcy Mootz, Ph.D., to its Board of Directors

Arbe Celebrates Milestone Achievements as Sensrad Announces Major Customer Orders for Revolutionary Radar Technology
CMRX

GlobeNewswire

a year ago

Arbe Celebrates Milestone Achievements as Sensrad Announces Major Customer Orders for Revolutionary Radar Technology

Toro Corp. Announces the Sale of the M/T Wonder Sirius for $33.8 Million with an Expected Net Gain of $20.9 Million
CMRX

GlobeNewswire

a year ago

Toro Corp. Announces the Sale of the M/T Wonder Sirius for $33.8 Million with an Expected Net Gain of $20.9 Million

Sidoti Events, LLC's Virtual January Micro-Cap Conference
CMRX

ACCESSWIRE

a year ago

Sidoti Events, LLC's Virtual January Micro-Cap Conference

American Resources Corporation's ReElement Technologies Engages Law Firm Alexander & Partner for Formation of ReElement Ghana
CMRX

ACCESSWIRE

a year ago

American Resources Corporation's ReElement Technologies Engages Law Firm Alexander & Partner for Formation of ReElement Ghana

HYZON ACHIEVES 2023 VEHICLE DEPLOYMENT AND FUEL CELL DEVELOPMENT MILESTONES
CMRX

PR Newswire

a year ago

HYZON ACHIEVES 2023 VEHICLE DEPLOYMENT AND FUEL CELL DEVELOPMENT MILESTONES

With 37% ownership, Immuneering Corporation (NASDAQ:IMRX) has piqued the interest of institutional investors
CMRX

Simply Wall St.

a year ago

With 37% ownership, Immuneering Corporation (NASDAQ:IMRX) has piqued the interest of institutional investors

Risky Retail: 3 Stocks Investors Should Avoid in 2024
CMRX

InvestorPlace

a year ago

Risky Retail: 3 Stocks Investors Should Avoid in 2024

Chimerix Appoints Lisa Decker to Board of Directors
CMRX

GlobeNewswire

a year ago

Chimerix Appoints Lisa Decker to Board of Directors

Osisko Development Announces Management Updates
CMRX

GlobeNewswire

a year ago

Osisko Development Announces Management Updates

ChromaDex Supports the US Military with its Industry Leading NAD+ Supplement, Tru Niagen®
CMRX

Business Wire

a year ago

ChromaDex Supports the US Military with its Industry Leading NAD+ Supplement, Tru Niagen®

Heritage Announces Closing of Primary Public Offering of Shares of Common Stock and Concurrent Private Placement
CMRX

PR Newswire

a year ago

Heritage Announces Closing of Primary Public Offering of Shares of Common Stock and Concurrent Private Placement

Insider Sell: EVP and COO David Sweitzer Sells 23,559 Shares of Quest Resource Holding Corp (QRHC)
CMRX

GuruFocus.com

a year ago

Insider Sell: EVP and COO David Sweitzer Sells 23,559 Shares of Quest Resource Holding Corp (QRHC)

3 Penny Stocks That Are About to Get Absolutely Crushed
CMRX

InvestorPlace

a year ago

3 Penny Stocks That Are About to Get Absolutely Crushed

Positive Signs As Multiple Insiders Buy Chimerix Stock
CMRX

Simply Wall St.

a year ago

Positive Signs As Multiple Insiders Buy Chimerix Stock

Share on Social Networks:

0

By browsing this website, you accept our Privacy Policy & Terms of Use